Back
Day Range
$17.52
$18.08
52-Week Range
$15.96
$44.34
Volume
1,581,103
50D / 200D Avg
$18.65
/
$26.93
Prev Close
$18.09
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -11.1 | 14.0 |
| P/B | 2.7 | 2.4 |
| ROE % | -22.6 | 11.4 |
| Net Margin % | -38.2 | 10.1 |
| Rev Growth 5Y % | 33.6 | 7.0 |
| D/E | 0.3 | 0.5 |
Key Takeaways
Revenue grew 33.63% annually over 5 years — strong growth
Debt/Equity of 0.31 — conservative balance sheet
Negative free cash flow of -158.89M
PEG of 0.29 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 18.30%
Capital efficient — spends only 1.76% of revenue on capex
Growth
Revenue Growth (5Y)
33.63%
Revenue (1Y)15.33%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-22.56%
ROIC-18.31%
Net Margin-38.15%
Op. Margin-49.86%
Safety
Debt / Equity
0.31
Current Ratio2.45
Interest Coverage-44.05
Valuation
P/E Ratio
-11.10
P/B Ratio2.72
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 15.33% | Revenue Growth (3Y) | 31.35% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33.63% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 460.16M | Net Income (TTM) | -175.54M |
| ROE | -22.56% | ROA | -14.97% |
| Gross Margin | 58.60% | Operating Margin | -49.86% |
| Net Margin | -38.15% | Free Cash Flow (TTM) | -158.89M |
| ROIC | -18.31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.31 | Current Ratio | 2.45 |
| Interest Coverage | -44.05 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.10 | P/B Ratio | 2.72 |
| P/S Ratio | 4.23 | PEG Ratio | 0.29 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.95B | Enterprise Value | 1.49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 460.16M | 398.99M | 266.72M | 215.04M | 144.31M |
| Net Income | -175.54M | -257.10M | -334.62M | -443.29M | -704.47M |
| EPS (Diluted) | -1.60 | -2.60 | -34.60 | -46.30 | -75.80 |
| Gross Profit | 269.64M | 251.13M | 170.90M | 141.02M | 92.07M |
| Operating Income | -229.43M | -282.12M | -366.57M | -404.36M | -700.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.17B | 1.19B | 1.04B | 1.22B | 1.61B |
| Total Liabilities | 456.88M | 344.86M | 240.18M | 174.55M | 230.00M |
| Shareholders' Equity | 715.50M | 840.90M | 796.12M | 1.05B | 1.38B |
| Total Debt | 224.26M | 153.47M | 15.15M | 20.39M | 15.54M |
| Cash & Equivalents | 679.57M | 449.67M | 790.15M | 1.01B | 964.10M |
| Current Assets | 1.02B | 1.05B | 939.61M | 1.12B | 1.50B |
| Current Liabilities | 416.17M | 299.39M | 203.07M | 139.84M | 192.90M |